Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (181-190 of 211) with videos related to

Pageof 22
Sort By:
European Journal of Cancer & Clinical Oncology|March 1, 1987
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomasV H Bramwell, H T Mouridsen, A Santoro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma GroupV H Bramwell, H T Mouridsen, A Santoro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II study of ifosfamide + adriamycin in advanced soft tissue sarcoma in adults. A preliminary analysisP Dombernowsky, H Mouridsen, J Schütte, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumoursP S Oturai, N H Holländer, O P Hansen, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1986
Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trialA Jakobsen, P L Frederiksen, K A Møller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow upU Lassen, P E Kristjansen, K Osterlind, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancerM Rozencweig, W ten Bokkel Huinink, F Cavalli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcomaJ Schütte, H T Mouridsen, W Steward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma GroupJ Schütte, H T Mouridsen, W Stewart, et al.
Breast Cancer Research and Treatment|August 15, 2000
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of ageC Rose, C Kamby, H T Mouridsen, et al.
Pageof 22

Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
European Journal of Cancer & Clinical Oncology|March 1, 1987
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomasV H Bramwell, H T Mouridsen, A Santoro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma GroupV H Bramwell, H T Mouridsen, A Santoro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II study of ifosfamide + adriamycin in advanced soft tissue sarcoma in adults. A preliminary analysisP Dombernowsky, H Mouridsen, J Schütte, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumoursP S Oturai, N H Holländer, O P Hansen, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1986
Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trialA Jakobsen, P L Frederiksen, K A Møller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow upU Lassen, P E Kristjansen, K Osterlind, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancerM Rozencweig, W ten Bokkel Huinink, F Cavalli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcomaJ Schütte, H T Mouridsen, W Steward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma GroupJ Schütte, H T Mouridsen, W Stewart, et al.
Breast Cancer Research and Treatment|August 15, 2000
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of ageC Rose, C Kamby, H T Mouridsen, et al.
Pageof 22